AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cartesian Therapeutics, Inc. Director's Dealing 2020

Jan 7, 2020

33483_dirs_2020-01-06_c3baff31-bdf8-4b09-9a04-88485392cf5c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2020-01-02

Reporting Person: Schecter Alison D. (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-02	Employee Stock Option (right to buy)	$2.3	A	100000	Acquired	2030-01-01	Common Stock (100000.0)	Direct

Footnotes

F1: This option will vest as to 25% on January 2, 2021. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.